Vivos Therapeutics, Inc. $VVOS

What the company doesAI summary of filing

Vivos Therapeutics is a revenue-stage medical technology and healthcare services company that develops and sells oral appliances and related therapeutic treatments for obstructive sleep apnea and related breathing disorders. The company's primary products are proprietary C.A.R.E. oral appliances (DNA, mRNA, and mmRNA devices) that are FDA-cleared for treating mild to severe OSA in adults and children, along with adjunctive therapies and diagnostic tools. The company generates revenue through appliance sales to trained dentists, diagnostic and treatment services from acquired or managed sleep centers, and ancillary services including home sleep testing, billing services, and myofunctional therapy. Since 2024, Vivos has pivoted toward a medical-provider focused model emphasizing direct acquisition and management of sleep medical practices and dental and medical service organizations, exemplified by its 2025 acquisition of The Sleep Center of Nevada, which generated approximately $6.8 million in revenue in 2025. [10-K 2026-04-15]

Segments: C.A.R.E. oral appliances (DNA, mRNA, mmRNA), Sleep Center and MSO/DSO operations, VivoScore home sleep testing, Treatment Navigator and billing services